BenevolentAI is the global leader in the development and application of artificial intelligence (“AI”) for scientific innovation. We aim to accelerate the journey from inventive ideas to medicines for patients by developing AI to generate new treatments for some of the world’s 8,000 untreated diseases.
Our team of technologists, AI researchers, and scientists builds and applies AI to the entire drug discovery and development process. The technology unlocks what is not known by creating new ideas based on established facts to provide a different understanding of disease, which leads to inventive steps and real insights that drive the development of new medicines and treatments.
- Headquarters Churchway, 40 , London, Greater London NW1 1LW, gb
- Other Locations 81 Prospect St, Brooklyn, New York 11201, us
- Year Founded 2013
- Company Size 51-200 employees
- Specialties Healthcare, Deep learning, Drug development, Scientific innovation, Bioscience
Accelerating the journey from data to medicine
- Sports & Entertainment |
- 0 Case Studies
- Agents / Bots |
- 3 Case Studies
Discover, Learn and Evaluate AI Companies and Solutions
The latest updates from AI companies in your industry
Get a weekly newsletter with the latest posts directly from the AI companies. Follow companies to tailor your feed.